Treatment of Breast Cancer-related Lymphedema With a Negative Pressure Device
3 other identifiers
interventional
28
1 country
1
Brief Summary
This study will be a 4 to 6 week randomized, controlled, assessor blinded, trial comparing a negative pressure massage device (intervention group), to the standard manual lymph drainage massage (control group), in breast cancer patients with chronic upper extremity lymphedema.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 10, 2017
CompletedFirst Posted
Study publicly available on registry
August 17, 2017
CompletedStudy Start
First participant enrolled
October 31, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2020
CompletedResults Posted
Study results publicly available
January 8, 2021
CompletedJanuary 15, 2021
December 1, 2020
2.3 years
August 10, 2017
November 13, 2020
January 13, 2021
Conditions
Outcome Measures
Primary Outcomes (2)
Recruitment Rates
The recruitment rate is defined as the number of women who were screened and then enrolled on the study divided by the the total number of women screened overall.
At 4 weeks
Percentage of Participants Who Completed All Study Visits
Retention rates for both arms of this study were evaluated. The numbers of women who completed the study will be recorded. Reasons for drop out will be ascertained.
At 4 weeks
Secondary Outcomes (28)
Mean Limb Volume
At Baseline
Mean Limb Volume
At 4 weeks
Mean Lymphedema Index (L-DEX®) Ratio Scores
At Baseline
Mean L-DEX® Scores
At 4 weeks
Mean Skin Induration Score
At Baseline
- +23 more secondary outcomes
Study Arms (2)
Negative Pressure
EXPERIMENTALPhysioTouch (negative pressure massage) treatment 3 times a week for 4 weeks to the lymphedematous upper limb
Manual Lymph Drainage
ACTIVE COMPARATORManual lymph drainage (MLD) treatment 3 times a week for 4 weeks to the lymphedematous upper limb
Interventions
The PhysioTouch is a hand-held device that administers negative pressure under the treatment head, and gently pulls the underlying skin and subcutaneous tissue into the suction cup. This suction produces a stretch to the skin and in the subcutaneous tissue space. This action is thought to facilitate lymphatic flow from the interstitium into the lymphatic vessels, and mobilizes the superficial fascia.
MLD is a practitioner-applied manual massage technique designed to decrease limb volume in patients with lymphedema by enhancing movement of lymph fluid, resulting in reductions in interstitial fluid.
Eligibility Criteria
You may qualify if:
- To be included women must be:
- Be over 18 years of age;
- Have had cancer treatment that included a surgical procedure, radiation therapy (RT), and/or chemotherapy (CTX);
- Have completed active cancer treatment at least 1 year prior to study enrollment;
- Have been diagnosed with lymphedema (LE) at least one year prior to study enrollment;
- Have arm lymphedema on one side only;
- Have confirmed LE based on bioimpedance measurements with an L-Dex® score of \>7.1 (note - this is very mild lymphedema);
- Have stable arm LE. LE will be considered "stable" if during the 3 months prior to study enrollment there was no arm infection requiring antibiotics, no change in ability to perform activities of daily living related to LE, and no subjective report of significant persistent changes in limb volume;
- Be mentally and physically able to participate in the study;
- Be able to attend the sessions at the University of California, San Francisco (UCSF) Parnassus campus;
- Read and understand English;
- Be able to understand a written informed consent document and the willingness to sign it
You may not qualify if:
- Women cannot have:
- Bilateral upper extremity LE;
- Current infection or lymphangitis involving the affected arm;
- Current recurrence of their breast cancer (BC) (local or distant)
- Pre-existing LE prior to their BC diagnosis;
- A condition that precludes measurement of LE using Bioimpedance Spectroscopy (BIS), including pregnancy;
- Current venous thrombosis in either upper extremity or be on current anticoagulant therapy;
- Extremity edema due to heart failure
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of California San Francisco
San Francisco, California, 94158, United States
Related Publications (1)
Lampinen R, Lee JQ, Leano J, Miaskowski C, Mastick J, Brinker L, Topp K, Smoot B. Treatment of Breast Cancer-Related Lymphedema Using Negative Pressure Massage: A Pilot Randomized Controlled Trial. Arch Phys Med Rehabil. 2021 Aug;102(8):1465-1472.e2. doi: 10.1016/j.apmr.2021.03.022. Epub 2021 Apr 16.
PMID: 33872573DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Betty Smoot, DPTSc, PT
- Organization
- University of California, San Francisco
Study Officials
- PRINCIPAL INVESTIGATOR
Betty Smoot, DPTSc, MAS
University of California, San Francisco
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 10, 2017
First Posted
August 17, 2017
Study Start
October 31, 2017
Primary Completion
January 31, 2020
Study Completion
January 31, 2020
Last Updated
January 15, 2021
Results First Posted
January 8, 2021
Record last verified: 2020-12
Data Sharing
- IPD Sharing
- Will not share